Showing results (21-30 of 53) with videos related to
Sort By:
Pageof 6
Breast Cancer Research and Treatment|August 15, 2022
Dose-dependent relation between metformin and the risk of hormone receptor-positive, her2-negative breast cancer among postmenopausal women with type-2 diabetesSoumya G Chikermane, Manvi Sharma, Susan M Abughosh, et al.Pharmacotherapy|June 8, 2013
Development of acneiform rash does not predict response to lapatinib treatment in patients with breast cancerJennifer Parma, Anne Pavlick, Rachel Schiff, et al.Clinical Breast Cancer|July 17, 2020
Oral Endocrine Therapy Agent, Race/Ethnicity, and Time on Therapy Predict Adherence in Breast Cancer Patients in a Large Academic InstitutionGrace S Hwang, Rutugandha Paranjpe, Carine Opsomer, et al.International Journal of Clinical Pharmacy|November 25, 2025
Identification of factors associated with non-adherence to oral endocrine therapy in breast cancer patients of low socioeconomic status: a single centre retrospective studyGowri Kalyani, Cynthia Ma, Phillip Shayne Pruneda, et al.Cardio-Oncology (London, England)|March 27, 2024
Comparing the effects of various β-blockers on cardiovascular mortality in breast cancer patientsMantasha Tabassum, Soumya G Chikermane, Camille Johnson, et al.Patient Preference and Adherence|March 7, 2025
Group-Based Trajectory Modeling to Identify Patterns and Predictors of Adherence to Oral Endocrine Therapies in Underserved Population of Greater Houston AreaYashvi Patel, Hasan Alsaedi, Zahra Majd, et al.Journal of Cancer Survivorship : Research and Practice|February 4, 2018
Interventions to improve endocrine therapy adherence in breast cancer survivors: what is the evidence?Ekim Ekinci, Salima Nathoo, Thushara Korattyil, et al.Cancer Chemotherapy and Pharmacology|October 9, 2013
Transient severe hyperbilirubinemia after hepatic arterial infusion of oxaliplatin in patients with liver metastasesSean S Garcia, Johnique T Atkins, Gerald S Falchook, et al.Communications Biology|May 5, 2026
Targeting the IRE1α-XBP1 signaling axis impairs tumor growth and promotes myogenic differentiation in rhabdomyosarcomaAnh Tuan Vuong, Aniket S Joshi, Phuong T Ho, et al.Biorxiv : the Preprint Server for Biology|May 4, 2026
Targeting the IRE1α-XBP1 signaling axis impairs tumor growth and promotes myogenic differentiation in rhabdomyosarcomaAnh Tuan Vuong, Aniket S Joshi, Phuong T Ho, et al.Pageof 6